Critical Care Nutritional Products Market Size, Share and Global Trend By Route of Administration (Enteral, Parenteral), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers, Others), and Regional Forecast, 2024-2032

Critical care nutritional products refer to the products used to facilitate the administration of optimal and safe nutrition to patients admitted to the Intensive Care Unit (ICU), using a practice based on evidence. Critical care nutritional products are crucial because early nutrition therapy may decrease the severity of the disease, reduce complications, decrease the length of stay in the intensive care unit, decrease mortality rates and improve patient outcomes. Critical care nutritional products have various routes of administration such as oral, enteral and parenteral.

Critical care nutritional products are especially important for patients undergoing surgery in order to prevent starvation, providing adequate nutrition and to modify the metabolic response to surgical stress. A number of factors such as optimal dose, timing, composition, and advancement rate of nutrition influence the administration of these products during the acute, chronic and recovery phases of the critical illness. The American Cancer Society estimates that in 2018, there were an estimated 1,735,350 new cancer cases diagnosed in the U.S., for which treatment using surgery is a common method.

One of the key drivers of the growth in the market is the increasing prevalence of acute and chronic diseases such as cancer for which treatment and management of individual often have to undergo several days of stay at the critical care. The World Federation of Societies of Anesthesiologists (WFSA) estimated that every year around 230 million major surgeries take place globally, thus necessitating the proper provision of adequate nutrition in order to improve patient outcomes and also improve the metabolic response to surgeries.

Another factor which adds to the considerable growth of the critical care nutritional products market is the extensive stays at the critical care units, due to increasing instances of trauma and accidents globally, requiring the best possible nutrition administration, leading to faster recoveries.

The factor that is expected to inhibit the growth of the market is the risks associated with the enteral administration of patient infections. Often these risks and complications can be life-threatening for the patients and some of the complications can include aspiration, refeeding syndrome, tube malpositioning or dislodgment, refeeding syndrome and fluid imbalances amongst others.

Key Players Covered

Some of the major companies that are present in the global critical care nutritional products market are Nestlé Health Science, Abbott, Fresenius Kabi AG, Danone, Mead Johnson & Company, LLC, Baxter and B. Braun Melsungen AG, and other players.

SEGMENTATION

At present, the enteral segment of the route of administration is projected to hold the largest proportion of the market because it is very widely used in patients admitted in critical care.

Key Insights

• New product launches
• Overview of opportunity assessment in new therapeutic areas
• Guidelines of critical care nutrition
• Overview of strategies by key market players

Regional Analysis

The global critical care nutritional products market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are anticipated to be the two largest markets for critical care nutritional products at present and they are expected to account for a large proportion of the market in the forecast period as well. This is because of the developed healthcare infrastructure with special emphasis on critical care coupled with technological advances in critical care nutritional feeding techniques. In the Asia Pacific region, Japan is expected to provide the largest market opportunity. This is because Japan has an extensively developed healthcare infrastructure with greater facilities and developed guidelines for critical care patients. In emerging markets such as India and China, there will be greater demand for advanced critical care nutritional products due to increased awareness and increased disposable incomes.

Key Industry Developments

• In October 2018, Baxter and the American Society for Parenteral and Enteral Nutrition (ASPEN) launched a collaboration for the reinforcement of the appropriate use of parenteral nutrition. The collaboration gave rise to the development of SmartPN, an educational initiative to help reduce clinical malnutrition.
• In September 2018, Baxter unveiled its product offering of Olimel 7.6% High Protein Nutrition Formulation at the 2018 Congress of the European Society of Clinical Nutrition and Metabolism (ESPEN).
• In April 2017, Abbott introduced the science-based nutrition drinks to better aid the patients prepare and recover in a better way from surgeries. Their product offerings include Ensure Surgery Immunonutrition Shake and Ensure Pre-Surgery Clear Nutrition Drink